PRODUCT

HGH 191AA (10IU Vial)

No short description available.

Quickstart Highlights

HGH 191AA is recombinant human growth hormone (somatropin) identical to endogenous GH, studied extensively for its effects on body composition, metabolism, and tissue repair[1][7]. Clinical protocols typically employ subcutaneous administration once daily to mimic physiological GH secretion patterns[2][3]. This educational protocol presents a gradual titration approach using practical dilution for precise insulin-syringe measurements.

Reconstitute: Add 3.0 mL bacteriostatic water → ~1.11 mg/mL concentration (~1111 mcg/mL).
Typical daily range: 150–500 mcg (conservative replacement protocols)[1] to 1000–2000 mcg (advanced metabolic studies)[4].
Easy measuring: At 1.11 mg/mL, 1 unit = 0.01 mL ≈ 11.1 mcg on a U-100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Reconstitution

Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake vigorously to preserve protein structure) [5] .
Label and refrigerate at 2–8 °C (35.6–46.4 °F) , protected from light.
Gently swirl/roll until dissolved (do not shake vigorously to preserve protein structure)[5].
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Protocol Overview

Goal:Support increases in lean body mass, reductions in adipose tissue, and enhanced metabolic function[7][8].
Schedule:Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired for advanced protocols).
Dose Range:Conservative: 150–500 mcg daily[1]; Advanced: 1000–2000 mcg daily[4].
Reconstitution:3.0 mL per 3.33 mg vial (~1.11 mg/mL) for accurate unit measurements.
Storage:Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Dosage Protocols

Start:200 mcg daily; increase by ~100 mcg each week as tolerated.
Conservative Target:400–900 mcg daily by Weeks 4–8[1][8].
Advanced Target:1000–1300 mcg daily by Weeks 9–12 (performance/metabolic research protocols)[4].
Frequency:Once per day (subcutaneous), preferably at bedtime[2].
Cycle Length:8–12 weeks standard; optional extension to 16 weeks with appropriate monitoring.
Timing:Evening or bedtime administration preferred; rotate injection sites systematically[3].

Storage Instructions

Lyophilized:Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure.
Reconstituted:Refrigerate at 2–8 °C (35.6–46.4 °F); stable for several weeks when stored properly[5].

Important Notes

Practical considerations for consistency and safety.

Use new sterile insulin syringes for each injection; dispose in a sharps container.
Rotate injection sites systematically (abdomen, thighs, upper arms) to reduce local irritation and prevent lipoatrophy[3].
Inject slowly; wait a few seconds before withdrawing the needle to minimize leakage.
Document daily dose, injection site, and any observed effects to maintain consistency and track tolerance.
HGH must be administered by injection; oral administration would be ineffective due to peptide degradation in the digestive system[6].

How It Works

HGH 191AA is recombinant human growth hormone (somatropin) that is structurally identical to endogenous GH secreted by the pituitary gland[1][5]. Clinical studies demonstrate that GH administration promotes increases in lean body mass, reductions in adipose tissue, and improvements in body composition through multiple mechanisms including enhanced lipolysis, increased protein synthesis, and stimulation of IGF-1 production[7][8]. Pivotal research by Rudman and colleagues showed that six months of HGH administration in older men significantly increased lean body mass and decreased adipose mass compared to placebo[7]. Long-term follow-up studies in adults with GH deficiency have demonstrated sustained improvements in muscle strength and body composition with maintenance dosing[8]. Subcutaneous administration once daily, particularly at bedtime, is designed to mimic physiological patterns of endogenous GH secretion[2][3]. Dosing protocols vary based on therapeutic goals: conservative replacement protocols typically employ 150–500 mcg daily[1], while advanced metabolic and performance research protocols may utilize 1000–2000 mcg daily[4]. Higher doses produce more pronounced physiological effects but also carry increased risk of side effects including fluid retention, joint discomfort, and potential metabolic disturbances[2].

Lifestyle Factors

Maintain adequate protein intake (1.6–2.2 g/kg body weight) to support anabolic processes stimulated by GH.
Combine resistance training and progressive overload to maximize lean mass gains and strength improvements.
Include cardiovascular activity to enhance metabolic adaptations and fat oxidation.
Prioritize sleep quality and duration (7–9 hours) to support endogenous recovery processes.
Manage stress and cortisol levels, as chronic stress can interfere with GH signaling and metabolic outcomes.
Ensure adequate hydration, particularly at higher doses where fluid retention may occur.

Injection Technique

Clean the vial stopper and injection site with alcohol; allow to air dry completely.
Pinch a skinfold at the injection site; insert the needle at 45–90° into subcutaneous tissue[11].
Do not aspirate for subcutaneous injections; inject slowly and steadily[11].
Rotate sites systematically (abdomen, thighs, upper arms) to prevent lipohypertrophy and lipoatrophy[3][13].
Common subcutaneous sites: abdomen (at least 2 inches from navel), outer thighs, upper arms (posterior surface)[12].
Wait a few seconds after injection before withdrawing needle to minimize solution leakage.

Benefits and Side Effects

Benefits

Observations from clinical research literature.

HGH 191AA (10IU Vial)

Resources

Categories

Company